Literature DB >> 25636424

The pre-analytical phase in surgical pathology.

Gianni Bussolati1, Laura Annaratone, Francesca Maletta.   

Abstract

Several sequential passages are involved in the pre-analytical handling of surgical specimens from resection in the surgical theater to paraffin-embedding and storage. Each passage is highly critical and can significantly affect the preservation of morphology, antigens, and nucleic acids. Some key points in this process are still undefined and are subject to high variability among hospitals. High quality and standardization are demanded and pathologists should therefore work to comply with all novel clinical requests (such as genomic and antigenic testing for targeted molecular therapies). Under-vacuum sealing of surgical pieces can be a safe and reliable alternative to storage in large formalin-filled boxes; it prevents dehydration and favors cooling by removing air. Moreover, it implements tissue banking and preservation of nucleic acids. After transport of specimens to pathological anatomy laboratories, the next passage, fixation, has been the object of several attempt to find alternatives to formalin. However, none of the substitutes proved successful, and formalin fixation is still considered the gold standard for preservation of morphology and antigens. RNA has instead been found to be heavily affected by degradation and fragmentation in formalin-fixed tissues. Based on the hypothesis that RNA degradation would be inhibited by maintaining a low temperature, a protocol based on processing tissues with formalin at low temperature (cold fixation) was evaluated and proved useful in obtaining a reduction in RNA fragmentation. Finally, the problem of storage is discussed, in order to find ways to guarantee feasibility of molecular analyses even years after the original diagnosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25636424     DOI: 10.1007/978-3-319-13957-9_1

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  13 in total

Review 1.  Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists.

Authors:  Nicola Fusco; Moira Ragazzi; Elham Sajjadi; Konstantinos Venetis; Roberto Piciotti; Stefania Morganti; Giacomo Santandrea; Giuseppe Nicolò Fanelli; Luca Despini; Marco Invernizzi; Bruna Cerbelli; Cristian Scatena; Carmen Criscitiello
Journal:  Histol Histopathol       Date:  2021-09-29       Impact factor: 2.303

Review 2.  Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer.

Authors:  Pasquale Pisapia; Francesco Pepe; Antonino Iaccarino; Roberta Sgariglia; Mariantonia Nacchio; Floriana Conticelli; Maria Salatiello; Rossella Tufano; Gianluca Russo; Gianluca Gragnano; Ilaria Girolami; Albino Eccher; Umberto Malapelle; Giancarlo Troncone
Journal:  Front Med (Lausanne)       Date:  2021-02-11

3.  Pathological examination of breast cancer samples before and after neoadjuvant therapy: recommendations from the Italian Group for the Study of Breast Pathology - Italian Society of Pathology (GIPaM-SIAPeC).

Authors:  Nicola Fusco; Antonio Rizzo; Leopoldo Costarelli; Alfredo Santinelli; Bruna Cerbelli; Cristian Scatena; Ettore Macrì; Francesca Pietribiasi; Giulia d'Amati; Anna Sapino; Isabella Castellano
Journal:  Pathologica       Date:  2022-04-13

Review 4.  Testing for ROS1 in non-small cell lung cancer: a review with recommendations.

Authors:  Lukas Bubendorf; Reinhard Büttner; Fouad Al-Dayel; Manfred Dietel; Göran Elmberger; Keith Kerr; Fernando López-Ríos; Antonio Marchetti; Büge Öz; Patrick Pauwels; Frédérique Penault-Llorca; Giulio Rossi; Aleš Ryška; Erik Thunnissen
Journal:  Virchows Arch       Date:  2016-08-17       Impact factor: 4.064

Review 5.  PD-L1 testing, fit for routine evaluation? From a pathologist's point of view.

Authors:  Georg Hutarew
Journal:  Memo       Date:  2016-10-28

6.  FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics.

Authors:  Stella Petroni; Lucia Caldarola; Rachele Scamarcio; Francesco Giotta; Agnese Latorre; Anita Mangia; Giovanni Simone
Journal:  Oncol Lett       Date:  2016-09-13       Impact factor: 2.967

Review 7.  Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?

Authors:  Véronique Hofman; Sandra Lassalle; Coraline Bence; Elodie Long-Mira; Sacha Nahon-Estève; Simon Heeke; Virginie Lespinet-Fabre; Catherine Butori; Marius Ilié; Paul Hofman
Journal:  Cancers (Basel)       Date:  2018-03-13       Impact factor: 6.639

Review 8.  Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization.

Authors:  Elham Sajjadi; Konstantinos Venetis; Roberto Piciotti; Marco Invernizzi; Elena Guerini-Rocco; Svasti Haricharan; Nicola Fusco
Journal:  Cancer Cell Int       Date:  2021-05-17       Impact factor: 5.722

9.  Cold Formalin Fixation Guarantees DNA Integrity in Formalin Fixed Paraffin Embedded Tissues: Premises for a Better Quality of Diagnostic and Experimental Pathology With a Specific Impact on Breast Cancer.

Authors:  Enrico Berrino; Laura Annaratone; Umberto Miglio; Elena Maldi; Chiara Piccinelli; Erica Peano; Davide Balmativola; Paola Cassoni; Alberto Pisacane; Ivana Sarotto; Tiziana Venesio; Anna Sapino; Caterina Marchiò
Journal:  Front Oncol       Date:  2020-02-19       Impact factor: 6.244

Review 10.  Basic principles of biobanking: from biological samples to precision medicine for patients.

Authors:  Laura Annaratone; Giuseppe De Palma; Giuseppina Bonizzi; Anna Sapino; Gerardo Botti; Enrico Berrino; Chiara Mannelli; Pamela Arcella; Simona Di Martino; Agostino Steffan; Maria Grazia Daidone; Vincenzo Canzonieri; Barbara Parodi; Angelo Virgilio Paradiso; Massimo Barberis; Caterina Marchiò
Journal:  Virchows Arch       Date:  2021-07-13       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.